Parag Saxena

Insider Reports History

Entity
Individual
Location
250 West 55 Th Street, Suite 13 D, New York, New York
Signature
/s/ Parag Saxena, on behalf of Vedanta Partners, LLC, by Parag Saxena, its CEO
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Parag Saxena:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REVIVA PHARMACEUTICALS HOLDINGS, INC. Director, 10%+ Owner Common Stock Warrant (right to buy) 585K Nov 20, 2023 Indirect
REVIVA PHARMACEUTICALS HOLDINGS, INC. Director, 10%+ Owner Pre-Funded Warrant 585K Nov 20, 2023 Indirect
REVIVA PHARMACEUTICALS HOLDINGS, INC. Director, 10%+ Owner Stock Option (right to buy) 8.2K Nov 13, 2023 Direct

Insider Reports Filed by Parag Saxena

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RVPH REVIVA PHARMACEUTICALS HOLDINGS, INC. Nov 20, 2023 2 $0 4 Nov 22, 2023 Director, 10%+ Owner
RVPH REVIVA PHARMACEUTICALS HOLDINGS, INC. Nov 13, 2023 1 $0 4 Nov 14, 2023 Director, 10%+ Owner
RVPH REVIVA PHARMACEUTICALS HOLDINGS, INC. Nov 10, 2022 1 $0 4 Nov 14, 2022 Director, 10%+ Owner
RVPH REVIVA PHARMACEUTICALS HOLDINGS, INC. Dec 8, 2021 1 $0 4 Dec 10, 2021 Director, 10%+ Owner
RVPH REVIVA PHARMACEUTICALS HOLDINGS, INC. Jun 15, 2021 1 $0 4 Jun 16, 2021 Director, 10%+ Owner